Exelixis
EXEL
#1562
Rank
ยฃ10.51 B
Marketcap
ยฃ42.45
Share price
-0.21%
Change (1 day)
48.09%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company